Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00492102 · ClinicalTrials.gov registry record · Phase 1
Montelukast in Very Low Birthweight Infants
A Phase 1 study of Bronchopulmonary Dysplasia, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT00492102: Completed Phase 1 study of Bronchopulmonary Dysplasia, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT00492102 is a Phase 1 study of Bronchopulmonary Dysplasia that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 9 participants, below the 236-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00492102, a Phase 1 study of Bronchopulmonary Dysplasia, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the pharmacokinetics (PK) of montelukast (Singulair) in very low birth weight (VLBW) infants at risk for developing bronchopulmonary dysplasia (the need for supplemental oxygen). The investigators' long-term hypothesis is that inhibition of leukotriene signaling in the VLBW preterm lung will decrease inflammation, remodeling and the incidence of bronchopulmonary dysplasia (BPD).
Conditions Studied
Interventions
- DRUG Montelukast
Study Locations (1)
Ohio
- Good Samaritan Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
What the finished NCT00492102 record still lists
NCT00492102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 236-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which Montelukast is the first listed.
NCT00492102 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00492102 about?
NCT00492102 is a clinical study titled "Montelukast in Very Low Birthweight Infants". The purpose of this study is to determine the pharmacokinetics (PK) of montelukast (Singulair) in very low birth weight (VLBW) infants at risk for developing bronchopulmonary dysplasia (the need for supplemental oxygen). The investigators' long-term hypothesis is that inhibition of leukotriene signa...
What is the current status of trial NCT00492102?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2007-03. Estimated completion is 2011-06.
What conditions does trial NCT00492102 study?
This clinical trial studies the following conditions: Bronchopulmonary Dysplasia.
What interventions are being tested in trial NCT00492102?
The interventions under investigation include: Montelukast (DRUG).
Who is sponsoring clinical trial NCT00492102?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00492102 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchopulmonary Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00492102's enrollment target sits among peer trials
9 30th of 29 the lowest of 29 other Bronchopulmonary Dysplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bronchopulmonary Dysplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Inhaled Ciclesonide Study in Preterm Infants
RECRUITING · Phase 1
-
Delivery Room CPAP in Extremely Low Birth Weight Infants
COMPLETED · Phase 1
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
RECRUITING · NA
-
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
RECRUITING
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia